Investment Summary

TPG and Montreux Equity Partners Exits M8 Pharmaceuticals

On September 20, 2023, Acino invested in life science company M8 Pharmaceuticals from TPG and Montreux Equity Partners

Investment Highlights
  • This is Acino’s 4th transaction in the Life Science sector.
  • This is Acino’s 1st transaction in the United States.
  • This is Acino’s 1st transaction in Pennsylvania.

Investment Summary

Date 2023-09-20
Target M8 Pharmaceuticals
Sector Life Science
Investor(s) Acino
Sellers(s) TPG
Montreux Equity Partners
Deal Type Add-on Acquisition
Advisor(s) Stifel
Credit Suisse Investment Banking
UBS Investment Bank (Financial)

Target

M8 Pharmaceuticals

Brewyn, Pennsylvania, United States
M8 Pharmaceuticals is a pharmaceutical company focused on licensing, marketing, and distributing therapeutics serving Brazil and Latin American markets. M8 Pharmaceuticals was founded in 2007 and is based in Berwyn, Pennsylvania.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Acino

Zurich, Czech Republic

Category Company
Founded 1836
Sector Life Science
Employees2,400
DESCRIPTION

Acino is a pharmaceutical company focused on developing, manufacturing and marketing well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino was founded in 1836 and is based in Zurich, Czech Republic.


DEAL STATS #
Overall 7 of 7
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 2 of 2
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-01 Aspen Pharmacare Holdings - Prescription Medicines

Durban, South Africa

Aspen brands portfolio includes the Trustan, Altosec, Zuvamor, Ciavor, Grantryl, and Aspen Granisetron brands.

Buy €105M

Seller(S) 2

SELLER

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 296.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


DEAL STATS #
Overall 260 of 277
Sector: Life Science M&A 31 of 33
Type: Add-on Acquisition M&A Deals 91 of 96
State: Pennsylvania M&A 7 of 7
Country: United States M&A 188 of 199
Year: 2023 M&A 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-07 CAA

Los Angeles, California, United States

CAA is a talent and literary agency that represents the most creative and successful artists working in music, film, television, theatre, sports, and games, and provides a range of strategic marketing services to corporate clients. CAA was founded in 1975 and is based in Los Angeles, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-11 AmSpec

Cranbury, New Jersey, United States

AmSpec is a provider of testing, inspection and certification services for petroleum traders and refiners. AmSpec provides independent and precise analysis and measurement of petroleum and petrochemical products across the US, Caribbean, Latin America, and globally. AmSpec was founded in 1986 and is based in Cranbury, New Jersey.

Buy -
DESCRIPTION

Montreux Equity Partners is a growth investment firm focused on investing in commercial stage companies with category leading products, technologies, and services. Montreux Equity Partners looks to invest $10 to $20 million in fast growing companies with $5 to $50 million in revenue. Montreux Equity Partners was formed in 1993 and is headquartered in San Francisco, California.


DEAL STATS #
Overall 24 of 24
Sector: Life Science M&A 9 of 9
Type: Add-on Acquisition M&A Deals 15 of 15
State: Pennsylvania M&A 1 of 1
Country: United States M&A 24 of 24
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-12 FinPay

King of Prussia, Pennsylvania, United States

FinPay enhances the patient financial experience by providing the education, transparency, and payment options that make patient financial responsibility digestible and affordable to the patient. FinPay is based in King of Prussia, Pennsylvania.

Buy -